NLRP3 and acute respiratory distress syndrome: These results suggest that the anti-inflammatory effect of glibenclamide is specifically related to NLRP3 inflammasome signaling pathway in LPS-induced ALI, though it could inhibit Th2 cytokines in ovalbumin-induced mouse model of asthma in our previous study [32].